Karnataka mulls compulsory rural service for medical students who opt for free seats

News Network
June 24, 2018

Hubballi, Jun 24: D K Shivakumar, Minister for Medical Education has proposed compulsory rural service for medical students who opt for free seats in Karnataka.
Speaking to media persons chairing a review meeting at the Karnataka Institute of Medical Sciences (KIMS) in here yesterday, he said that the government is contemplating a hike in the fees of government medical colleges.

He said that the government spends approximately Rs 10 lakh on the education of each medical student. On the other hand, students pay a fee of just Rs 16,000 a year.

“Compared to the fee structure of private colleges, fees at government colleges are reasonably low,” he said. A student who wishes to study medicine at a government college will be able to pay a little more for his studies,” he said.

Of the Rs 16,000 fees a student pays, the Rajiv Gandhi University of Health Sciences, Bengaluru collects Rs 9,000 and the medical colleges are left with very little funds for programme enhancement. The fee hike is intended to make these colleges financially independent and not to fill the coffers of government, he said.

Based on the inputs received at the meeting, Shivakumar said he would consider making rural service compulsory for MBBS students who get free medical seats. “The government is not interested in levying monetary fines on students. That method has failed to yield the desired results and is also being contested in court. Hence, we will look into the Maharashtra model, where doctors will not get a permanent registration number without serving for a certain period in rural areas,” he said and added that this would address the 70%-75% vacancy of doctors in rural areas.

He also instructed all the government medical colleges to video record their moveable and non-moveable assets. A detailed report of the equipment purchased and their present condition should be submitted to the government soon, based on which an audit will be held, he said. These instructions came after it was brought to his notice that equipment in hospitals was being stolen. Recently, equipment worth lakhs of rupees was found in a medical officer’s house in Hubballi. “There is a need to fix accountability on the hospital property and this move will ensure that equipment doesn’t go missing,” he said.

Comments

Forcing medical graduates to do rural service is one aspect only. .The other aspect (improving living conditions, better education facilities for children, better roads & sanitary conditions etc) also should be addressed for optimum results

Vivek
 - 
Sunday, 24 Jun 2018

Shortage of good doctors in rural area is already exists. Anyway this may be a relief

Suresh
 - 
Sunday, 24 Jun 2018

Why young medical students are hesitated to do rural service. They want only cities and more money. What their ethics suggests..?

Ramprasad
 - 
Sunday, 24 Jun 2018

Rural service should be compulsory for medical students. They have to do rural service. Later they wont do anything for rural people and for less amount. So atleast as a part of their studies, it should be complusory thing

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
coastaldigest.com web desk
July 1,2020

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
January 22,2020

Bengaluru, Jan 22: Three alleged Bangladeshi nationals living illegally in India were apprehended in Karnataka's Bengaluru district, police said on Wednesday.

The arrested are identified as Mohammed Lokman (55), his wife Jasmin Begun (35) and son Raasel (22) are natives of Boresel village in Pirojpur district in Bangladesh.

According to police, they were staying at a camp at Munnekolala village.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 27,2020

Bengaluru, Mar 27: Oncologist Dr. Vishal Rao, HCG Hospital Bengaluru on Friday said that human body cells release interferon chemical to kill viruses but it cannot be released by cells in the case of COVID-19 cases, leading to weak immune system. However, a therapy of specific concoction could be useful in treating COVID-19 patients.

"We got hold of some preprint suggesting that interferon is effective in COVID19," said Rao.

Speaking to news agency, he continued saying "When we withdraw blood for regular check-ups, we get buffy coat which can be used to take out cells and form interferon. These two chemicals and some other cytokines, in a specific concoction, could be potentially very useful in treating COVID-19 patients."

Rao said that they have built a concoction of cytokines which can be injected to reactivate immune system in COVID-19 patients.

"We are in a very initial stage and hope to be ready with its first set by this weekend. We have applied to the governement for an expedited review. We have also presented this before the state government" said Rao.

"We have a team of infection specialist, ICU team and other...all of us have worked together to build something that we believe. We want to serve the society at this hour of need," he added.

Dr Rao clarified that this is not a vaccine and this particular interferon therapy does not help to prevent the infection of COVID-19. However, this is focused and targeted towards COVID-19 positive patients or those who have just incubated the virus.

"We believe that in early stages as well as the patients who have just incubated, this particular therapy of interferon gama and other concoction of cytokines could be an effective method. In the late stages we are looking at specific dosage of the cells which are our own body cells which can actually be affective and could also be of use for the ventilator patients," he added.

Meanwhile, Dr Gururaj, Immunologist and Scientist told ANI that they are trying to cover two aspects, one is the early stage patients where they are trying to improve their immune systems.

"As Dr Vishal said, we are trying to see whether we can use the cytokines from our own immune cells which is a natural process but it is hampered in infected patients," said Dr Gururaj.

"In the last phase we are using cells which are used from the bone marrow of the patient or donors. We can use those cells to reduce the inflation and so called cytokines release syndrome which is basically the inflammatory response of the body," he added.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.